Cite

HARVARD Citation

    Butzkueven, H. et al. (2014). Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results. Journal of neurology, neurosurgery and psychiatry. 85 (11), pp. 1190-1197. [Online]. 
  
Back to record